(Q28141398)

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

The role of complement and complement receptors in induction and regulation of immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Complement evasion strategies of microorganisms

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors. The Multi Center Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Complement factor H-binding protein of Raji cells and tonsil B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Regulation by membrane sialic acid of β1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Seeking wisdom in innate immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

The instructive role of innate immunity in the acquired immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Location of the complement factor H binding site on streptococcal M6 protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Natural immunity to Sindbis virus is influenced by host tissue sialic acid content

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Phylogenetic perspectives in innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Complement evasion by bacteria and parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Kinetic analysis of the amplification phase for activation and binding of C3 to encapsulated and nonencapsulated Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Murine protein H is comprised of 20 repeating units, 61 amino acids in length

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Characterization of the lymphocyte membrane receptor for factor H (beta 1H-globulin) with an antibody to anti-factor H idiotype

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

H deficiency in two brothers with atypical dense intramembranous deposit disease

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Control of the complement system.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Decay-Accelerating Factor and Membrane Cofactor Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Regulation of complement activation by C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

A New Model for Evaluation of Biocompatibility: Combined Determination of Neoepitopes in Blood and on Artificial Surfaces Demonstrates Reduced Complement Activation by Immobilization of Heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Complement C3 convertase: Cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

The alternative pathway of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Oligomeric domain structure of human complement factor H by X-ray and neutron solution scattering.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Familial hemolytic-uremic syndrome and homozygous factor H deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

HIV glycoprotein 41 and complement factor H interact with each other and share functional as well as antigenic homology

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

The complete amino acid sequence of human complement factor H

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Purification and structural studies on the complement-system control protein beta 1H (Factor H).

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Molecular modelling of C3 and its ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

The human factor H-related protein 4 (FHR-4). A novel short consensus repeat-containing protein is associated with human triglyceride-rich lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Complement systems in invertebrates. The ancient alternative and lectin pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55).

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Control of the amplification convertase of complement by the plasma protein beta1H

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

The alternative pathway C3 convertase and glomerular deposits

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Modulation of the alternative complement pathways by beta 1 H globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Complement factor H and related proteins: an expanding family of complement-regulatory proteins?

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

The factor H protein family

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

Factor H and disease: a complement regulator affects vital body functions.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2980300-8

7 January 2021

10.1016/S0162-3109(00)80300-8

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1193559

1193559

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference